Editor's Note The Joint Commission, on February 22, announced that it had approved new and revised requirements for hospitals and critical access hospitals in the Patient Blood Management certification program. The program is a voluntary 2-year certification based on the Association for the Advancement of Blood and Biotherapies Standards for…
Takeaways Gun-related violence is an increasing threat in healthcare settings, including perianesthesia departments and ASCs. Small hospitals and ACS are not immune to active shooter events. New requirements from The Joint Commission require planning and preparation for active shooter events. Elizabeth Dalton, BSN, RN, will never forget the day her…
Editor's Note The Texas Board of Nursing has charged 23 nurses with “fraudulently obtaining educational credentials” as part of a national scheme involving thousands of fraudulent nursing degrees, the February 20 Becker’s Hospital Review reports. The nursing students paid thousands of dollars to the individuals running the scheme and are…
Editor's Note The Food and Drug Administration (FDA) on February 16 identified the recall by Philips Respironics of certain reworked Trilogy 100, Trilogy 200, and Garbin Plus ventilators as Class I, the most serious. The recall was initiated because of the potential for silicone foam adhesive failure and residual polyester-based…
Editor's Note This study led by researchers at the University of Michigan Medical School, Ann Arbor, finds that cardiopulmonary, financial, and functional problems were highly prevalent in patients at 6 months after COVID-19 hospitalization. This analysis includes a national US cohort of 825 adults discharged from 44 hospitals after COVID-19…
Editor's Note North American Partners in Anesthesia’s (NAPA) Anesthesia Risk Alerts (ARA) program provides anesthesia clinicians with novel mitigation strategies to better manage five high-risk scenarios in the perioperative setting. Implemented in April 2019, NAPA’s nationwide healthcare partners have achieved 95% compliance screening for the scenarios and have performed secondary…
Editor's Note The Food and Drug Administration (FDA) on February 15 identified the recall by GE HealthCare of its Nuclear Medicine 600/800 Series systems as Class I, the most serious. The recall was initiated because of an issue with two mechanisms that prevent uncontrolled detector movement. If the mechanisms fail,…
Editor's Note This study from the University of Michigan, Ann Arbor, finds that network facilities had higher negotiated prices for surgical procedures, and there is wide variability across facilities in and out of hospital networks. A total of 3,195 hospitals were included in the analysis. Among the findings: For 15…
Editor's Note The Food and Drug Administration (FDA) on February 8 identified the recall by Universal Meditech Inc of its Skippack Medical Lab SARS-CoV-2 Antigen Rapid Test (Colloidal Gold) as Class I, the most serious. The recall was initiated because the tests were distributed to US customers without authorization, clearance,…
Editor's Note The Food and Drug Administration (FDA) on February 2 identified the recall by Smiths Medical of certain CADDTM Infusion System Administration Sets and Cassette Reservoirs as Class I, the most serious. The recall was initiated because of tubing occlusion and false “no disposable attached” alarm issues, which may…